Safety Problems Lead To Early End For Study Of 'Abortion Pill Reversal'
Three of the 12 women enrolled in a study of progesterone to reverse a medication-based abortion required ambulance transport to a hospital for treatment of severe vaginal bleeding.
by Mara Gordon
Dec 05, 2019
3 minutes
A study designed to test the effectiveness of a controversial practice known as "abortion pill reversal" has been stopped early because of safety concerns.
Researchers from the University of California, Davis, were investigating claims that the hormone progesterone can stop a medication-based abortion after a patient has completed the first part of the two-step process.
For the study, the researchers aimed to enroll 40 women who were scheduled to have surgical abortions.
You’re reading a preview, subscribe to read more.
Start your free 30 days